COVID-19 poses unique challenges for CTEPH. Join our 4/21/20 webinar to learn more:
6:30PM ET https://t.co/nkIpDxWYH9 Enter program #: BAY0000376; State: New Jersey
8:30PM ET https://t.co/fALo5MaKUo Enter program #: BAY0000377; State: New Jersey
Sunday, July 14th is the deadline to submit your letter of intent for the Pulmonary
Hypertension Accelerated Bayer (PHAB) Awards. Visit https://t.co/Q9fJP2MXFZ to learn more.
The deadline to submit your letter of intent for the Pulmonary Hypertension Accelerated Bayer
(PHAB) Awards grant program is July 14th. Visit https://t.co/Q9fJP2MXFZ to learn more.
Bayer is offering the Pulmonary Hypertension Accelerated Bayer (PHAB) Awards. Bayer is
providing up to $1 million in grants over a 2-year period to support clinical research in
pulmonary hypertension with focus on PAH & CTEPH. Visit https://t.co/Q9fJP34z4z to learn more.